Immunocore Holdings PLC
NASDAQ:IMCR

Watchlist Manager
Immunocore Holdings PLC Logo
Immunocore Holdings PLC
NASDAQ:IMCR
Watchlist
Price: 33.44 USD -2.14%
Market Cap: 1.7B USD
Have any thoughts about
Immunocore Holdings PLC?
Write Note

Immunocore Holdings PLC
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immunocore Holdings PLC
Income from Continuing Operations Peer Comparison

Comparables:
CNTA
EXAI
AUTL
BCYC
GNS

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Immunocore Holdings PLC
NASDAQ:IMCR
Income from Continuing Operations
-ÂŁ55.3m
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Income from Continuing Operations
-$151.1m
CAGR 3-Years
-142%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Income from Continuing Operations
-ÂŁ146m
CAGR 3-Years
-72%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Income from Continuing Operations
-$208.4m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Income from Continuing Operations
-$166.3m
CAGR 3-Years
-36%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Income from Continuing Operations
ÂŁ2.4m
CAGR 3-Years
-63%
CAGR 5-Years
-19%
CAGR 10-Years
-22%

See Also

What is Immunocore Holdings PLC's Income from Continuing Operations?
Income from Continuing Operations
-55.3m GBP

Based on the financial report for Dec 31, 2023, Immunocore Holdings PLC's Income from Continuing Operations amounts to -55.3m GBP.

What is Immunocore Holdings PLC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
5%

Over the last year, the Income from Continuing Operations growth was -34%. The average annual Income from Continuing Operations growth rates for Immunocore Holdings PLC have been 9% over the past three years , 5% over the past five years .

Back to Top